Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥2.27T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥1.16T2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥3.98T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.89T2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥956.8bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥118.4bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥50.3bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥153.1bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥66.1bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥122.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥46.9bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥290.4bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥147.2bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥61.9bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥73.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥29.1bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥177.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥85.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥35.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥91.5bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥38.2bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥209.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥101.9bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥42.7bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥6.00Tat 2022-09-30Cons.Assets IFRS
Total assets¥5.57Tat 2022-03-31Cons.Assets IFRS
Total assets¥5.32Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.96Tat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥3.73Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥2.04Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥1.84Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.67Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.57Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.63Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.32Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥253.7bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥245.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥257.7bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥349.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥93.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥346.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥166.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥117.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥128.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥107.5bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥15.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥336.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥151.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.022022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥20.442022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥124.682021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥59.942021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥24.82021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥49.792022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.582022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥115.032021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥55.132021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.822021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio27.1%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.8%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥205.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥108.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥96.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥6.6bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥152.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥152.9bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥6.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue2022-04-01 → 2022-09-30¥771.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue external2022-04-01 → 2022-09-30¥745.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥26.0bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentsegment profit2022-04-01 → 2022-09-30¥22.7bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥212.3bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥212.0bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥309m
jpcrp040300-q2r_E00808-000Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥3.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2022-04-01 → 2022-09-30¥573.7bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2022-04-01 → 2022-09-30¥569.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2022-04-01 → 2022-09-30¥54.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥659.7bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥634.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥25.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥42.3bn
—segment totalrevenue2022-04-01 → 2022-09-30¥2.22T
—segment totalrevenue external2022-04-01 → 2022-09-30¥2.16T
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥56.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥122.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥2.42T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥2.27T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥152.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥129.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥172.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥81.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥90.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥6.1bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥140.6bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥140.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥7.3bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue2021-04-01 → 2021-09-30¥614.8bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue external2021-04-01 → 2021-09-30¥593.9bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥20.9bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentsegment profit2021-04-01 → 2021-09-30¥62.2bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue2021-04-01 → 2021-09-30¥198.7bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue external2021-04-01 → 2021-09-30¥198.5bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥171m
jpcrp040300-q2r_E00808-000Health Carereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2021-04-01 → 2021-09-30¥447.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2021-04-01 → 2021-09-30¥444.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2021-04-01 → 2021-09-30¥48.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥592.2bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥566.7bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥25.5bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥45.8bn
—segment totalrevenue2021-04-01 → 2021-09-30¥1.85T
—segment totalrevenue external2021-04-01 → 2021-09-30¥1.80T
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥49.8bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥157.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥2.03T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.89T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥140.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥163.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 950
ItemContextValueUnit
Revenue IFRSCurrentYTDDuration2269808000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00808-000PerformanceProductsReportableSegmentMember42264000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00808-000ChemicalsReportableSegmentMember22739000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember54252000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00808-000HealthCareReportableSegmentMember3146000000JPY
Segment profit loss IFRSCurrentYTDDuration_ReportableSegmentsMember122401000000JPY
Segment profit loss IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember6649000000JPY
Segment profit loss IFRSCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember129050000000JPY
Segment profit loss IFRSCurrentYTDDuration_ReconcilingItemsMember-6429000000JPY
Segment profit loss IFRSCurrentYTDDuration122621000000JPY
Segment profit loss IFRSPrior1YTDDuration156140000000JPY
Segment profit loss IFRSCurrentYTDDuration122621000000JPY
Gain on reversal of environmental expenses IFRSPrior1YTDDuration-JPY
Gain on reversal of environmental expenses IFRSCurrentYTDDuration2389000000JPY
Gain on sale of fixed assets adjustments to profit before tax IFRSPrior1YTDDuration1782000000JPY
Gain on sale of fixed assets adjustments to profit before tax IFRSCurrentYTDDuration647000000JPY
Gain on sale of investments in subsidiaries and associates adjustments to profit before tax IFRSPrior1YTDDuration1886000000JPY
Gain on sale of investments in subsidiaries and associates adjustments to profit before tax IFRSCurrentYTDDuration-JPY
Loss on arbitration award IFRSPrior1YTDDuration-JPY
Loss on arbitration award IFRSCurrentYTDDuration3502000000JPY
Impairment losses adjustments to profit before tax IFRSPrior1YTDDuration1898000000JPY
Impairment losses adjustments to profit before tax IFRSCurrentYTDDuration1894000000JPY
Loss on sale and retirement of fixed assets adjustments to profit before tax IFRSPrior1YTDDuration2702000000JPY
Loss on sale and retirement of fixed assets adjustments to profit before tax IFRSCurrentYTDDuration1411000000JPY
Other adjustments to profit before tax IFRSPrior1YTDDuration2071000000JPY
Other adjustments to profit before tax IFRSCurrentYTDDuration498000000JPY
Operating profit loss IFRSPrior1YTDDuration153137000000JPY
Operating profit loss IFRSCurrentYTDDuration118352000000JPY
Finance income IFRSPrior1YTDDuration5418000000JPY
Finance income IFRSCurrentYTDDuration16538000000JPY
Finance costs IFRSPrior1YTDDuration11390000000JPY
Finance costs IFRSCurrentYTDDuration12923000000JPY
Profit loss before tax IFRSPrior1YTDDuration147165000000JPY
Profit loss before tax IFRSCurrentYTDDuration121967000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の4の7第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-11-11
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第18期第2四半期(自 2022年7月1日 至 2022年9月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)三菱ケミカルグループ株式会社
Company name in english cover pageFilingDateInstantMitsubishi Chemical Group Corporation
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)執行役社長    ジョンマーク・ギルソン
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内一丁目1番1号
Telephone number address of registered headquarter cover pageFilingDateInstant(03)6748-7200
Name of contact person address of registered headquarter cover pageFilingDateInstantText · Plus
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区丸の内一丁目1番1号
Telephone number nearest place of contact cover pageFilingDateInstant(03)6748-7200
Name of contact person nearest place of contact cover pageFilingDateInstantText · Plus
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00808

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass